Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03372161 · ClinicalTrials.gov registry record · Phase 3
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
A Phase 3 study of Lumbosacral Radicular Pain, sponsored by Scilex Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 401
- Enrollment target
- 20
- Study locations
NCT03372161: Completed Phase 3 study of Lumbosacral Radicular Pain, sponsored by Scilex Pharmaceuticals.
NCT03372161 is a Phase 3 study of Lumbosacral Radicular Pain that has completed, run by Scilex Pharmaceuticals. The registered enrollment target is 401 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (48% lower). The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03372161, a Phase 3 study of Lumbosacral Radicular Pain, has completed, sponsored by Scilex Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 401 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a research study of SP-102, an experimental medication designed to relieve pain in patients with a specific type of leg pain. The medication is given once by your healthcare professional, with a possibility of a second injection as early as about 1 month after the first treatment. The purpose of the study is to measure how well a single injection of the experimental medication, SP-102, relieves pain. The study will also investigate the side effects of SP-102.
Primary Outcome
The NPRS is an 11-point scale (0 to 10-point scale where 0 was no pain and 10 was worst pain imaginable) that allowed the subject to rate the severity of their pain intensity at various points in time.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG SP-102
Study Locations (20)
Florida
- Semnur Research Site 56 - Fernandina Beach
- Semnur Research Site 81 - Jacksonville
- Semnur Research Site 49 - St. Petersburg
- Semnur Research Site 13 - Tampa
- Semnur Research Site 61 - Tampa
- Semnur Research Site 53 - Winter Park
Illinois
- Semnur Research Site 40 - Bloomington
- Semnur Research Site 63 - Chicago
- Semnur Research Site 12 - Chicago
- Semnur Research Site 19 - Chicago
California
- Semnur Research Site 18 - La Jolla
- Semnur Research Site 47 - Laguna Woods
- Semnur Research Site 70 - Los Gatos
Georgia
- Semnur Research Site 28 - Marietta
- Semnur Research Site 64 - Marietta
- Semnur Research Site 10 - Newnan
Arizona
- Semnur Research Site 52 - Phoenix
- Semnur Research Site 58 - Tempe
Alabama
- Semnur Research Site 75 - Mobile
Idaho
- Semnur Research Site 38 - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2017-12-08 |
| Est. Completion | 2022-01-06 |
| Phase | Phase 3 |
What the finished NCT03372161 record still lists
NCT03372161 is an interventional study that assigns participants to a tested intervention. The registered 401 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Lumbosacral Radicular Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03372161 names 20 study sites across 7 states, led by Florida, Illinois, California.
Frequently Asked Questions
What is clinical trial NCT03372161 about?
NCT03372161 is a clinical study titled "Corticosteroid Lumbar Epidural Analgesia for Radiculopathy". This is a research study of SP-102, an experimental medication designed to relieve pain in patients with a specific type of leg pain. The medication is given once by your healthcare professional, with a possibility of a second injection as early as about 1 month after the first treatment. The purpo...
What is the current status of trial NCT03372161?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 401 participants. The study started on 2017-12-08. Estimated completion is 2022-01-06.
What conditions does trial NCT03372161 study?
This clinical trial studies the following conditions: Lumbosacral Radicular Pain.
What interventions are being tested in trial NCT03372161?
The interventions under investigation include: Placebo (DRUG), SP-102 (DRUG).
Who is sponsoring clinical trial NCT03372161?
This trial is sponsored by Scilex Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03372161 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03372161's enrollment target sits among peer trials
401 921st of 2000 higher than 1,079 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI